Sara Labiano

3.5k total citations
41 papers, 2.1k citations indexed

About

Sara Labiano is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Sara Labiano has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 26 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Sara Labiano's work include Immunotherapy and Immune Responses (22 papers), Immune Cell Function and Interaction (20 papers) and CAR-T cell therapy research (17 papers). Sara Labiano is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), Immune Cell Function and Interaction (20 papers) and CAR-T cell therapy research (17 papers). Sara Labiano collaborates with scholars based in Spain, United States and United Kingdom. Sara Labiano's co-authors include Ignacio Melero, Arantza Azpilikueta, María E. Rodríguez-Ruiz, Alfonso R. Sánchez-Paulete, José Luis Perez‐Gracia, M. Ángela Aznar, Miguel F. Sanmamed, Elixabet Bolaños, Aizea Morales‐Kastresana and Maria Jure–Kunkel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Sara Labiano

41 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Labiano Spain 20 1.5k 1.4k 398 189 166 41 2.1k
Arantza Azpilikueta Spain 26 1.8k 1.2× 1.6k 1.1× 438 1.1× 144 0.8× 180 1.1× 47 2.4k
Michelle M. Langhan United States 8 1.3k 0.9× 1.6k 1.2× 344 0.9× 98 0.5× 291 1.8× 10 1.9k
Nikolina Bąbała Netherlands 9 1.3k 0.8× 1.0k 0.7× 509 1.3× 183 1.0× 87 0.5× 11 1.8k
Inmaculada Rodríguez Spain 19 991 0.6× 1.0k 0.7× 285 0.7× 88 0.5× 118 0.7× 24 1.5k
Natalia Aptsiauri Spain 31 1.9k 1.3× 1.6k 1.1× 726 1.8× 175 0.9× 157 0.9× 55 2.9k
Jesse M. Zaretsky United States 8 1.3k 0.9× 1.5k 1.1× 518 1.3× 183 1.0× 67 0.4× 16 2.1k
Colm R. Duffy United States 4 1.1k 0.7× 1.6k 1.2× 514 1.3× 209 1.1× 79 0.5× 11 2.3k
Jeanette Baker United States 26 2.3k 1.5× 1.2k 0.9× 333 0.8× 76 0.4× 155 0.9× 65 3.1k
Ninke Leffers Netherlands 21 1.6k 1.0× 1.7k 1.2× 363 0.9× 218 1.2× 90 0.5× 26 2.5k
Lukasz K. Chlewicki United States 10 1.3k 0.8× 987 0.7× 315 0.8× 91 0.5× 73 0.4× 15 1.7k

Countries citing papers authored by Sara Labiano

Since Specialization
Citations

This map shows the geographic impact of Sara Labiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Labiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Labiano more than expected).

Fields of papers citing papers by Sara Labiano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Labiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Labiano. The network helps show where Sara Labiano may publish in the future.

Co-authorship network of co-authors of Sara Labiano

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Labiano. A scholar is included among the top collaborators of Sara Labiano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Labiano. Sara Labiano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Labiano, Sara, et al.. (2023). Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry. STAR Protocols. 5(1). 102803–102803. 1 indexed citations
2.
Labiano, Sara, et al.. (2022). Assessment of hypoxia by pimonidazole staining following radiotherapy. Methods in cell biology. 172. 179–189. 5 indexed citations
3.
Labiano, Sara, Vincent Roh, Jackeline F. Romero, et al.. (2021). CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors. Clinical Cancer Research. 27(14). 4054–4065. 27 indexed citations
4.
Puigdelloses, Montse, Marc García-Moure, Sara Labiano, et al.. (2021). CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models. Journal for ImmunoTherapy of Cancer. 9(7). e002644–e002644. 31 indexed citations
5.
Martínez-Usatorre, Amaia, et al.. (2020). Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells. Frontiers in Immunology. 11. 340–340. 28 indexed citations
6.
Teijeira, Álvaro, Sara Labiano, Saray Garasa, et al.. (2018). Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation. Cancer Immunology Research. 6(7). 798–811. 65 indexed citations
7.
Sánchez-Paulete, Alfonso R., Álvaro Teijeira, José I. Quetglas, et al.. (2018). Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming. Cancer Research. 78(23). 6643–6654. 69 indexed citations
8.
Labiano, Sara, et al.. (2018). Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy. Frontiers in Immunology. 9. 2076–2076. 75 indexed citations
9.
Aznar, M. Ángela, Sara Labiano, Ángel Díaz‐Lagares, et al.. (2017). CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell–Relevant Genes. Cancer Immunology Research. 6(1). 69–78. 35 indexed citations
10.
Berraondo, Pedro, Sara Labiano, Luna Minute, et al.. (2017). Cellular immunotherapies for cancer. OncoImmunology. 6(5). e1306619–e1306619. 16 indexed citations
11.
Rodríguez-Ruiz, María E., Inmaculada Rodríguez, Saray Garasa, et al.. (2016). Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming. Cancer Research. 76(20). 5994–6005. 198 indexed citations
12.
Alfaro, Carlos, Álvaro Teijeira, Carmen Oñate, et al.. (2016). Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs). Clinical Cancer Research. 22(15). 3924–3936. 316 indexed citations
13.
Sánchez-Paulete, Alfonso R., Francisco J. Cueto, María Martínez‐López, et al.. (2015). Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti–PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells. Cancer Discovery. 6(1). 71–79. 362 indexed citations
14.
Sanmamed, Miguel F., Inmaculada Rodríguez, Kurt A. Schalper, et al.. (2015). Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2−/−IL2Rγnull Immunodeficient Mice. Cancer Research. 75(17). 3466–3478. 129 indexed citations
15.
Weigelin, Bettina, Elixabet Bolaños, Álvaro Teijeira, et al.. (2015). Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb. Proceedings of the National Academy of Sciences. 112(24). 7551–7556. 81 indexed citations
16.
Quetglas, José I., Sara Labiano, M. Ángela Aznar, et al.. (2015). Virotherapy with a Semliki Forest Virus–Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade. Cancer Immunology Research. 3(5). 449–454. 89 indexed citations
17.
Labiano, Sara, Asís Palazón, Elixabet Bolaños, et al.. (2015). Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism. OncoImmunology. 5(1). e1062967–e1062967. 52 indexed citations
18.
Morales‐Kastresana, Aizea, Sara Labiano, Ines Gütgemann, & Ignacio Melero. (2014). Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer. OncoImmunology. 3(2). e27812–e27812. 3 indexed citations
19.
Perez‐Gracia, José Luis, Sara Labiano, María E. Rodríguez-Ruiz, Miguel F. Sanmamed, & Ignacio Melero. (2014). Orchestrating immune check-point blockade for cancer immunotherapy in combinations. Current Opinion in Immunology. 27. 89–97. 94 indexed citations
20.
Morales‐Kastresana, Aizea, Miguel F. Sanmamed, Inmaculada Rodríguez, et al.. (2013). Combined Immunostimulatory Monoclonal Antibodies Extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model. Clinical Cancer Research. 19(22). 6151–6162. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arantza Azpilikueta Breakdown of academic impact, for papers by Michelle M. Langhan Breakdown of academic impact, for papers by Nikolina Bąbała Breakdown of academic impact, for papers by Inmaculada Rodríguez Breakdown of academic impact, for papers by Natalia Aptsiauri Breakdown of academic impact, for papers by Jesse M. Zaretsky Breakdown of academic impact, for papers by Colm R. Duffy Breakdown of academic impact, for papers by Jeanette Baker Breakdown of academic impact, for papers by Ninke Leffers Breakdown of academic impact, for papers by Lukasz K. Chlewicki
Rankless by CCL
2026